KENNEY CHRISTOPHER JOHN
Insider CIK 1880129 · XENE Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-08-28 | 2026-08-31 | 700 | $60.98 | $42.7K | 2 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-08-28 | 2026-08-31 | 6,368 | $60.17 | $383.2K | 702 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-08-28 | 2026-08-31 | 700 | $60.98 | $42.7K | 2 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-08-28 | 2026-08-31 | 6,368 | $60.17 | $383.1K | 702 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-13 | 2026-03-13 | 1,410 | $55.23 | $77.9K | 7,069 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-03-12 | 2026-03-13 | 3,750 | — | $0 | 11,250 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-03-12 | 2026-03-13 | 3,750 | — | $0 | 8,479 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2026-03-10 | 2026-03-11 | 2,771 | $60.11 | $166.6K | 4,729 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-03-09 | 2026-03-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-03-09 | 2026-03-11 | 7,500 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-03-09 | 2026-03-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-01-09 | 2026-01-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-01-09 | 2026-01-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-03-12 | 2025-03-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-03-12 | 2025-03-13 | 80,000 | — | $0 | 80,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2024-03-11 | 2024-03-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2023-03-24 | 2023-03-24 | 700 | $35.01 | $24.5K | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2023-03-10 | 2023-03-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2022-03-10 | 2022-03-14 | 125,000 | — | $0 | 125,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2022-01-21 | 2022-01-21 | 700 | $28.81 | $20.2K | 700 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-08-23 | 2021-08-25 | 150,000 | — | $0 | 150,000 | SEC↗ |